CLINICAL ROLE -
Study Shows Semaglutide Holds Promise in Reducing Alcohol Cravings
Treatment with semaglutide yielded superior effects on drinking outcomes compared with existing therapies to reduce alcohol cravings.
Read More
Study Finds Central Obesity Measures More Accurate for Assessing Colorectal Cancer Risk Than BMI
Using central obesity measures provides more accurate estimates of the proportion of CRC cases attributable to excess weight compared to using BMI alone.
Fluctuating Cholesterol Over Time Associated With Dementia Risk in Older Adults
There was an association observed between fluctuating low-density lipoprotein cholesterol and the risk of developing dementia and cognitive impairment.
Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency
Improvements in baseline for markers of hemolysis (indirect bilirubin, lactate dehydrogenase, and haptoglobin) were observed only in the mitapivat arm.
Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes
Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.
Watch
FDA Grants Priority Review to Zongertinib for Treatment of HER2-Mutated, Advanced Non-Small Cell Lung Cancer
Priority review status will allow for expedited development of zongertinib, putting it on the path toward approval as the first in a new class of drugs for mutated NSCLC.
Research Shows Infusing Isatuximab in Just 30 Minutes Provides Same Safety
The 75 minutes of infusion time typically required is costly and difficult for patients.
New and Evolving: Pretreatment Risk Factors for Pneumonitis and Trastuzumab-Deruxtecan
T-DXd has a boxed warning for interstitial lung disease and pneumonitis.
Single-Dose Malaria Vaccine Demonstrates 90% Efficacy in Early Trials
PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world.
Pharmacists Play Vital Role in Stroke Prevention
Educating patients about lifestyle modifications is a critical part of preventing cerebrovascular events.
Focusing Treatment on Multiple Pathways to Reduce Resistance and Improve Outcomes in Triple-Positive Breast Cancer
Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.
Novel Blood Test Detects Early-Stage Pancreatic Cancer With 85% Accuracy
The test offers an accurate, fast, low-cost, and noninvasive tool for early diagnosis of pancreatic ductal adenocarcinoma.
Managing Endometriosis Treatment: Pharmacists as Key Partners in Patient Care
Pharmacists play a vital role in supporting patients with endometriosis through guidance on treatment options and managing side effects.
Pharmacists Can Improve Specialty Medication Management in Dermatology
Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.
Later-Onset Menopause Associated With a Lower Risk of Heart Disease, Study Finds
These findings may lead to new therapies to help reduce the risk of heart disease in women who are at risk.
Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation Antiandrogens
Treatment selection includes patient factors, cost, adverse effects, and drug interactions.
Prompting Better Care: Improving Conversations With Question Prompt Lists
QPL use in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise.
Video: Mitigating Adverse Events in IVIG Therapy for CIDP is Key Role of Care Team
Identifying and managing IVIG-related side effects early on in treatment can improve efficacy and safety for patients with CIDP.
Impact of RSV and hRV Coinfection on Respiratory Disease Severity
Coinfection with RSV and hRV is linked to a higher prevalence of lower respiratory tract infections, according to new data.
Pharmacists Help Patients Navigate Vaccine Schedules
Many patients may struggle to understand the complex immunization schedules compiled by the CDC.
CDC Study Raises Concerns Over Undetected H5N1 Infections in Humans
Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.
Larsucosterol Did Not Show Statistical Significance Compared With Placebo in Phase 2b AHFIRM Trial
Although larsucosterol did not show statistical significance, it showed clinically meaningful trends in 90-day mortality in patients with severe alcohol-associated hepatitis.
Sickle Cell Disease Management Requires Pharmacist Involvement in Multidisciplinary Care Team
Prescribing and dosing appropriate treatments for patients with sickle cell disease while managing episodes of acute pain are some of the integral roles of pharmacists.
Condition Watch: Biosimilars
Because Ned Said: Drug Shortage or Not, That Is the Question
All stakeholders should work together to determine and address drug shortages.
Expert Insight: Benefits, Safety, and Considerations of Protein Powders
Phil Vigeant shares insights on the health benefits of protein supplements and guidance for consumers to identify safe and effective protein powder products.
Children and Adolescents With Postacute COVID-19 Face Higher Risk of Poor Gastrointestinal Tract Outcomes
New data from the longest known trial of pediatrics and adolescents in the postacute phase of COVID-19 show they are at a heightened risk of gastrointestinal tract symptoms.
New Study Puts Community Pharmacists at Forefront of Diabetic Kidney Disease Therapy
Clinical decision support systems based on algorithms have improved outcomes and reduced costs in other health care settings.
Tarlatamab-dlle: A Beginning for Bispecific Therapies in Small Cell Lung Cancer
Second-line and later treatment options for small cell lung cancer are limited.